TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs

- Deliyannis, Georgia, Wong, Chinn Yi, McQuilten, Hayley A., Bachem, Annabell, Clarke, Michele, Jia, Xiaoxiao, Horrocks, Kylie, Zeng, Weiguang, Girkin, Jason, Scott, Nichollas E., Londrigan, Sarah L., Reading, Patrick C., Bartlett, Nathan W., Kedzierska, Katherine, Brown, Lorena E., Mercuri, Francesca, Demaison, Christophe, Jackson, David C., Chua, Brendon Y.

RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses

- Hayman, Thomas J., Hsu, Alan C., Wark, Peter A., Kedzierska, Katherine, Masters, Seth L., Belz, Gabrielle T., Binder, Marco, Hansbro, Philip M., Nicola, Nicos A., Nicholson, Sandra E., Kolesnik, Tatiana B., Dagley, Laura F., Willemsen, Joschka, Tate, Michelle D., Baker, Paul J., Kershaw, Nadia J., Kedzierski, Lukasz, Webb, Andrew I.

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

- Kedzierski, Lukasz, Tate, Michelle D., Bird, Nicola L., Chatfield, Simon M., Babon, Jeffrey J., Huntington, Nicholas, Belz, Gabrielle, Webb, Andrew, Wark, Peter A. B., Nicola, Nicos A., Xu, Jianqing, Kedzierska, Katherine, Hsu, Alan C., Hansbro, Philip M., Nicholson, Sandra E., Kolesnik, Tatiana B., Linossi, Edmond M., Dagley, Laura, Dong, Zhaoguang, Freeman, Sarah, Infusini, Giuseppe, Starkey, Malcolm R.